Literature DB >> 17131478

Noninvasive evaluation of hepatic fibrosis in children with infant hepatitis syndrome.

Zhi-Xian Li1, Yun He, Ji Wu, Dan-Mei Liang, Bu-Lin Zhang, Hong Yang, Ling-Ling Wang, Yun Ma, Kang-Lai Wei.   

Abstract

AIM: To elucidate the impact of hemodynamic para-meters on ultrasonography and serum fibrosis markers for the assessment of liver fibrosis in the children with infant hepatitis syndrome (IHS).
METHODS: Forty-one children with IHS and 46 healthy infants were examined by ultrasonography, and several hemodynamic indices such as peak systolic velocity (PSV) and resistant index (RI) of proper hepatic artery (PHA) were measured. Serum fibrosis markers including hyaluronic acid (HA), pre-collagen type-III (PC-III), collagen type IV (C-IV), and laminin (LN) were assayed by radioimmunoassays. In children with IHS, liver tissues were obtained either by ultrasound-guided liver biopsy (n = 35) or in the course of operation (n = 6). The stages of hepatic fibrosis were scored as mild (S1 and S2), moderate (S3), or severe (S4) according to liver histological diagnosis. Multiple groups comparative and Spearman correlative analyses were carried out.
RESULTS: Histopathologically, 39 children (95.1%) were found to have hepatic fibrosis, 12 of them stage S1 or S2, 12 stage S3, and 15 stage S4. PSV, RI of the PHA, and serum HA showed a consecutive increase from mild to severe hepatic fibrosis and a close positive correlation with hepatic fibrosis in IHS group (r = 0.717, 0.745 and 0.712, respectively, P = 0.001). The Doppler waveform of HV was also positively correlated with the degree of hepatic fibrosis in IHS group (r = 0.783, P < 0.001).
CONCLUSION: Combination of ultrasonic studies on the hepatic hemodynamics with the evaluation of serum HA may provide an indicator for hepatic fibrosis in patients with IHS. This may be a useful noninvasive method for the diagnosis and evaluation of the prognosis of IHS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131478      PMCID: PMC4087777          DOI: 10.3748/wjg.v12.i44.7155

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Proposed abdominal sonographic staging to predict severity of liver diseases: analysis with peritoneoscopy and histology.

Authors:  K N Khan; M Yamasaki; K Yamasaki; O Inoue; H Yatsuhashi; M Koga; M Yano
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  [Relationship between serum fibrosis markers and fibrosis quantitative analysis of liver tissue].

Authors:  S Gu; H Zhang; L Zhang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  1999-12

3.  Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.

Authors:  J G McHutchison; L M Blatt; M de Medina; J R Craig; A Conrad; E R Schiff; M J Tong
Journal:  J Gastroenterol Hepatol       Date:  2000-08       Impact factor: 4.029

4.  Sonographic measurements of the portal vein and its intrahepatic branches in children.

Authors:  A K Vocke; R Kardorff; J H Ehrich
Journal:  Eur J Ultrasound       Date:  1998-04

5.  Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

Authors:  C Pilette; M C Rousselet; P Bedossa; D Chappard; F Oberti; H Rifflet; M Y Maïga; Y Gallois; P Calès
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

6.  Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia.

Authors:  H Kobayashi; K Horikoshi; A Yamataka; T Yamataka; T Okazaki; G J Lane; T Miyano
Journal:  J Pediatr Surg       Date:  1999-12       Impact factor: 2.545

7.  Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B.

Authors:  N Pontinha; H Pessegueiro; H Barros
Journal:  Scand J Clin Lab Invest       Date:  1999-08       Impact factor: 1.713

8.  Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN.

Authors:  P Fabris; F Marranconi; L Bozzola; M R Biasin; F De Lazzari; M Plebani; P Benedetti; G Tositti; G Pellizzer; C Stecca; F de Lalla
Journal:  J Gastroenterol       Date:  1999-06       Impact factor: 7.527

9.  Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis.

Authors:  C Aubé; F Oberti; N Korali; M A Namour; D Loisel; J Y Tanguy; E Valsesia; C Pilette; M C Rousselet; P Bedossa; H Rifflet; M Y Maïga; D Penneau-Fontbonne; C Caron; P Calès
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

10.  Diagnosis of liver cirrhosis in children based on colour Doppler ultrasonography with histopathological correlation.

Authors:  D Tüney; M E Aribal; D Ertem; E Kotiloğlu; E Pehlivanoğlu
Journal:  Pediatr Radiol       Date:  1998-11
View more
  5 in total

1.  Serum fibronectin levels in acute and chronic viral hepatitis patients.

Authors:  Ayse Erturk; Erkan Cure; Zulal Ozkurt; Emine Parlak; Medine Cumhur Cure
Journal:  Malays J Med Sci       Date:  2014-01

2.  Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients.

Authors:  Steven Shinn-Forng Peng; Yung-Ming Jeng; Wen-Ming Hsu; Justin Cheng-Ta Yang; Ming-Chih Ho
Journal:  Eur Radiol       Date:  2015-04-29       Impact factor: 5.315

3.  Doppler ultrasound of hepatic and system hemodynamics in patients with alcoholic liver cirrhosis.

Authors:  Drazen Zekanovic; Zekanovic Drazen; Neven Ljubicic; Ljubicic Neven; Marko Boban; Boban Marko; Marko Nikolic; Nikolic Marko; Diana Delic-Brkljacic; Delic-Brkljacic Diana; Petar Gacina; Gacina Petar; Ivo Klarin; Klarin Ivo; Jadranko Turcinov; Turcinov Jadranko
Journal:  Dig Dis Sci       Date:  2009-03-10       Impact factor: 3.199

Review 4.  Is there a place for serum laminin determination in patients with liver disease and cancer?

Authors:  Heitor Rosa; Edison Roberto Parise
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

Review 5.  Limitations and opportunities of non-invasive liver stiffness measurement in children.

Authors:  Guido Engelmann; Jasmin Quader; Ulrike Teufel; Jens Peter Schenk
Journal:  World J Hepatol       Date:  2017-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.